HI
CHRS icon

Handelsinvest Investeringsforvaltning’s Coherus Oncology CHRS Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,200
Closed -$301K – 100
2016
Q1 		$301K Hold
14,200
– – 0.1% 108
2015
Q4 		$326K Buy
+14,200
New +$365K 0.11% 101

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's CHRS Position: Q2 2016 in Review

Handelsinvest Investeringsforvaltning sold out of Coherus Oncology (CHRS) in Q2 2016, closing a stake of 14,200 shares — an estimated $301K sold.

Handelsinvest Investeringsforvaltning first reported a position in CHRS in Q4 2015 and held it in 2 quarters. The position peaked at $326K in Q4 2015. 86 funds tracked by Wall St. Rank hold CHRS as of Q2 2016.

  • Handelsinvest Investeringsforvaltning reported no remaining Coherus Oncology position as of Q2 2016 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 14,200 Coherus Oncology shares in Q2 2016, an estimated $301K.
  • Handelsinvest Investeringsforvaltning first reported a position in Coherus Oncology in Q4 2015 and held it in 2 quarters.
  • Handelsinvest Investeringsforvaltning's Coherus Oncology position peaked at $326K in Q4 2015.
  • 86 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2016.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q2 2016, filed 8 Aug 2016.